Allele Biotechnology and Pharmaceuticals, Inc. v. Regeneron Pharmaceuticals, Inc.

Filing 109

ORDER. On November 16, 2022, counsel for Defendant Regeneron Pharmaceuticals, Inc. wrote to the Court, with Plaintiff Allele Biotechnology and Pharmaceuticals, Inc.'s consent, requesting that each party be allotted up to 75 minutes for the c laim construction hearing scheduled for November 21, 2022 at 10:30 a.m. That application is denied. The Court will endeavor to spend as much time as necessary to consider each partys position. SO ORDERED. (Signed by Judge Philip M. Halpern on 11/17/22) (yv)

Download PDF
Case 7:20-cv-08255-PMH Document 109 Filed 11/17/22 Page 1 of 1 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS, INC., ORDER Plaintiff, 20-CV-08255 (PMH) -againstREGENERON PHARMACEUTICALS, INC., Defendant. PHILIP M. HALPERN, United States District Judge: On November 16, 2022, counsel for Defendant Regeneron Pharmaceuticals, Inc. wrote to the Court, with Plaintiff Allele Biotechnology and Pharmaceuticals, Inc.’s consent, requesting that each party be allotted up to 75 minutes for the claim construction hearing scheduled for November 21, 2022 at 10:30 a.m. That application is denied. The Court will endeavor to spend as much time as necessary to consider each party’s position. SO ORDERED. Dated: White Plains, New York November 17, 2022 PHILIP M. HALPERN United States District Judge

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?